Sun Pharma shares under pressure after the USFDA flags a key unit
Sun Pharma said it continues to manufacture and supply approved products from the facility to the US market.
Uncategorized
Wobble in US AI stocks may benefit India, says Geosphere Capital’s Arvind Sanger
Arvind Sanger, Managing Partner, Geosphere Capital Management expressed hope that 2026 will mark a phase of earnings acceleration for Indian companies.
‘I think market is making a mistake’ — ICICI Pru AMC Co-CIO on why he avoids EMS companies
In an interaction with CNBC-TV18 on Thursday, December 18, Tawakley explained his rationale behind avoiding the space, that has been a wealth creator, barring the recent volatile sell-off and fall from peaks.
SEBI’s new mutual fund rules a ‘mixed bag’, may hurt research quality: Sandeep Parekh
Sandeep Parekh, Managing Partner at Finsec Law Advisors, believes the new brokerage cap will negatively affect the quality of institutional research available to funds and that the revised TER structure will favour large asset managers, potentially hindering distribution in smaller…
Aurobindo Pharma shares at day’s high despite arm’s unit getting form 483 from USFDA
Last week, the US drug regulator had issued another Form 483 with three observations to Aurobindo Pharma after inspecting its Unit-V, an active pharmaceutical ingredient (API) manufacturing facility of its wholly-owned subsidiary Apitoria Pharma Pvt. Ltd., in Telangana.
Tata Motors CV shares get a ‘buy’ rating from two analysts based on four key factors
JPMorgan is positive on the Tata Motors CV stock due to expectations of a modest recovery in the CV cycle after three years of no growth.
Hero MotoCorp shares fall after Jefferies downgrade, price target cut
While Jefferies remains constructive on the overall two wheeler demand outlook, it said that the GST cut driven demand boost has faded during November and December.
Govt orders probe against IndusInd Bank following auditor concerns
MCA ordered SFIO to probe IndusInd Bank over derivatives reporting after auditors flagged concerns to RBI.
Stocks To Buy — Motilal Oswal projects a 77% ‘bull case’ upside on this consumer durables stock
In its bull case estimate, Motilal Oswal has a price target of ₹460, which projects a 77% upside potential from Crompton Greaves Consumer Electricals’ current market price.
Motilal Oswal, HDFC AMC and other capital market shares in focus after latest SEBI changes
The brokerage cap on Mutual Fund cash trades has been kept at six basis points. SEBI has also approved removing the additional five basis points charged to mutual fund schemes with exit loads.